1. Application of sequencing, liquid biopsies and patient-derived xenografts for personalized medicine in melanoma. (July 2016) Authors: Girotti, M.R.; Gremel, G.; Lee, R.; Galvani, E.; Rothwell, D.; Mandal, A.K.; Lim, K.H.J.; Saturno, G.; Furney, S.J.; Baenke, F.; Pedersen, M.; Smith, M.; Fusi, A.; Dhomen, N.; Brady, G.; Lorigan, P.; Dive, C.; Marais, R. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessing the interplay of RNA-fusion events with cancer driver mutations in melanoma patients. (July 2016) Authors: Mandal, A.; Girotti, M.R.; Dhomen, N.; Viros, A.; Gremel, G.; Galvani, E.; Baenke, F.; Lee, R.; Lim, K.H.J.; Lorigan, P.; Marais, R. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. BRAF inhibition promotes BRAF mutant human melanoma cell survival under nutrient-deprived conditions through activation of mitochondrial metabolism. (July 2016) Authors: Delgado-Goni, T.; Wantuch, S.; Workman, P.; Marais, R.; Leach, M.O.; Beloueche-Babari, M. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Gene-specific interactions between ultraviolet radiation and melanoma. (July 2016) Authors: Viriós, A.; Pedersen, M.; Furney, S.J.; Girotti, M.R.; Hogan, K.; Saturno, G.; Galvani, E.; Sanchez-Laorden, B.; Ng, C.; Reis-Filho, J.S.; Lorigan, P.; Cook, M.; Marais, R. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Genomic analysis of multi-site fresh prostate samples. (July 2016) Authors: Parry, M.; Cannistraci, A.; Ramani, V.; Lau, M.; Shanks, J.; Nonaka, D.; Clarke, N.; Dhomen, N.; Baena, E.; Marais, R. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lysyl oxidase regulates EGFR signalling through the extracellular matrix. (July 2016) Authors: Tang, H.; Leung, L.; Saturno, G.; Viros, A.; Di Leva, G.; Morrison, E.; Smith, D.; Johnson, L.; Dhomen, N.; Springer, C.; Marais, R. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Metabolic rewiring in melanoma cell lines that acquired resistance to BRAF inhibitors. (July 2016) Authors: Baenke, F.; Chaneton, B.; Smith, M.; Van Den Broek, N.; Hogan, K.; Tang, H.; Viros, A.; Dhomen, N.; Gottlieb, E.; Marais, R. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Modelling anti-PD-1 treatment in a transgenic murine model of BRAFV600E-driven melanoma. (July 2016) Authors: Galvani, E.; Hogan, K.; Boon, L.; Gremel, G.; Viros, A.; Mandal, A.; Smith, M.; Swan, J.; Banyard, A.; Ashton, G.; Dhomen, N.; Marais, R. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients. (January 2018) Authors: Valpione, S.; Gremel, G.; Mundra, P.; Middlehurst, P.; Galvani, E.; Girotti, M.R.; Lee, R.J.; Garner, G.; Dhomen, N.; Lorigan, P.C.; Marais, R. Journal: European journal of cancer Issue: Volume 88(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Proffered Paper: Utilising non-mutational drug-tolerance prolongs and improves targeted melanoma therapy. (July 2016) Authors: Smith, M.P.; Brunton, H.; Rowling, E.J.; Girotti, M.R.; Marais, R.; Dummer, R.; Flaherty, K.T.; Cooper, Z.A.; Wargo, J.A.; Wellbrock, C. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗